Shares of Amgen Inc. rallied in the extended session Thursday after the drugmaker posted adjusted earnings above expectations and executives said they are “very encouraged” by preliminary data from a trial of an injectable weight-loss drug.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnShares of Amgen Inc. rallied in the extended session Thursday after the drugmaker posted adjusted earnings above expectations and executives said they are “very encouraged” by preliminary data from a trial of an injectable weight-loss drug.nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]